Penn Medicine, CHOP receive $25M anonymous gift to accelerate research in rare genetic brain disorders
The donation will establish the Center for Epilepsy and Neurodevelopmental Disorders, which will initially focus on developing therapies for disorders related to genetic mutations that are linked to a
Penn Scientists New Research Shows That a CAR-T gel Treatment May Be Able to Kill Residual Cancer Cells Left Over from Surgery
In the study, Penn scientists added CAR-T cells to a gel designed to prevent bleeding after surgery and applied it to the surgical wounds of mice after they had hard-to-treat tumors resected.
PCI Hosts its 7th Annual Innovation@Penn Conference
On January 9th, 2023 PCI was proud to present a star-studded program entitled “The Future of mRNA Technology” at Wharton San Francisco during the JP Morgan Healthcare Conference.
Karikó and Weissman named to the National Inventors Hall of Fame
Karikó and Weissman were named to the National Inventors Hall of Fame for their mRNA research which made covid-19 vaccines possible.
Penn’s Abramson Cancer Center Presents New Cancer Research at 2022 American Society of Hematology (ASH) Annual Meeting
Researchers from Penn’s Abramson Cancer Center presented the preliminary results of an ongoing Phase I clinical trial for a novel CAR T therapy to be used after cancer.
Penn spinout Neuralert Technologies’ stroke detection wristband selected for TIME’s List of the Best Inventions of 2022
The lightweight, non-invasive wristband device can detect the stroke symptoms in as little as 15 minutes.
Emily Whitehead’s CAR-T Cell Therapy Journey Featured on CBS
CBS This Morning recently featured a story about Emily Whitehead, the first pediatric patient to receive Penn-invented CAR T cell therapy to fight cancer.
Drew Weismann Speaks on the Future of mRNA Technology in Bloomberg’s “The Big Take” Podcast
Weissman talks about his discovery and the impact of mRNA technology on the development of therapies for flu, cancer and rare genetic diseases.
PCI Team Member and Penn Medicine Featured in Washington Post
Carter Caldwell, Director of the Penn Medicine Co-Investment Program, was featured in the Washington Post’s Medical Mysteries column which described his journey following life-changing brain surgery.
Penn Medicine and Candel Therapeutics partner to pursue potential solid tumor CAR T-cell therapy
The University of Pennsylvania’s Center for Cellular Immunotherapies, led by cell therapy pioneer Dr. Carl June, has entered into a cancer treatment collaboration with Candel Therapeutics.